ScoreWhy is Veracyte, Inc. ?
1
With a growth in Net Profit of 307.36%, the company declared Outstanding results in Mar 26
- The company has declared positive results for the last 2 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 166.16 MM
- PRE-TAX PROFIT(Q) At USD 26.59 MM has Grown at 385.84%
- NET PROFIT(Q) At USD 25.47 MM has Grown at 390.46%
2
With ROE of 5.50%, it has a fair valuation with a 1.82 Price to Book Value
- Over the past year, while the stock has generated a return of 91.67%, its profits have risen by 127.2% ; the PEG ratio of the company is 0.3
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
- Along with generating 91.67% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Veracyte, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Veracyte, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Veracyte, Inc.
91.67%
2.38
61.14%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
34.50%
EBIT Growth (5y)
31.71%
EBIT to Interest (avg)
-14.55
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.37
Tax Ratio
5.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0.63%
ROE (avg)
0.76%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
1.82
EV to EBIT
30.72
EV to EBITDA
23.05
EV to Capital Employed
2.19
EV to Sales
3.82
PEG Ratio
0.27
Dividend Yield
NA
ROCE (Latest)
7.14%
ROE (Latest)
5.50%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 166.16 MM
PRE-TAX PROFIT(Q)
At USD 26.59 MM has Grown at 385.84%
NET PROFIT(Q)
At USD 25.47 MM has Grown at 390.46%
ROCE(HY)
Highest at 6.93%
RAW MATERIAL COST(Y)
Fallen by -7.07% (YoY
CASH AND EQV(HY)
Highest at USD 851.95 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -29.73 %
DEBTORS TURNOVER RATIO(HY)
Highest at 10.43 times
-1What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 7.13 times
Here's what is working for Veracyte, Inc.
Pre-Tax Profit
At USD 26.59 MM has Grown at 385.84%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 25.47 MM has Grown at 390.46%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD 166.16 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Cash and Eqv
Highest at USD 851.95 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at -29.73 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 10.43 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -7.07% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Veracyte, Inc.
Inventory Turnover Ratio
Lowest at 7.13 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
